Table 1 Study design and dosing schedule... | American Society of Hematology

Table 1

Study design and dosing schedule

Group	N	Doses and administration schedule
Group	N	3H9, 0.6 mg/kg IV	Vehicle, SC daily	ALX-0681, 2.5 mg/kg SC daily
Control animals	4	d 1, 3, 5, 7, 9	d 1-11
Preventive ALX-0681–treated animals	4	d 1 and 3		d 1-5
Therapeutic ALX-0681–treated animals	4	d 1, 3, 5, 7, 9	d 1-4	d 5-11

Group	N	Doses and administration schedule
Group	N	3H9, 0.6 mg/kg IV	Vehicle, SC daily	ALX-0681, 2.5 mg/kg SC daily
Control animals	4	d 1, 3, 5, 7, 9	d 1-11
Preventive ALX-0681–treated animals	4	d 1 and 3		d 1-5
Therapeutic ALX-0681–treated animals	4	d 1, 3, 5, 7, 9	d 1-4	d 5-11

Table shows an overview of the timing of injections in the different study groups.